EUVIMEDEUVIMED entdecken
Vergleichsstudie

What is the optimal fractionation for image-based high-dose-rate brachytherapy boost in medically inoperable endometrial cancer: 4 versus 5 fractions?

Abigail Groszkiewicz, Jamie L Lesnock, Paniti Sukumvanich, Michelle Boisen, Madeleine Courtney-Brooks, Jessica Berger, Sarah Taylor, Alexander Olawaiye, Alison Garrett, Shannon Rush, Michael Hajduk, Christopher Houser und 3 weitere

Brachytherapy · 2026-07 · 25 (4) · 616-623

DOI: 10.1016/j.brachy.2026.02.001 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Brachytherapy, 2026-07. Verfasst von Abigail Groszkiewicz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: groszkiewicza2@upmc.edu. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Brachytherapy, Dose Fractionation, Radiation, Radiotherapy, Image-Guided. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE For the treatment of medically inoperable endometrial cancer, there is currently no standard recommended fractionation regimen for brachytherapy boost after completion of external beam radiotherapy (EBRT). This study compares disease control and toxicity with 4 fractions (Fx) versus 5 Fx of brachytherapy. MATERIALS AND METHODS Single institution retrospective review of medically inoperable patients treated with EBRT followed by high-dose-rate (HDR) brachytherapy boost. Brachytherapy was performed using three-dimensional image-based planning with magnetic resonance (MR) imaging each fraction when able and was delivered as either 25 Gy in 5 Fx or 24 Gy in 4 Fx based on a transition in the institutional standard. Primary endpoints were locoregional failure (LRF) and late toxicity. RESULTS Ninety-four patients were included; 5 Fx n = 64, 4 Fx n = 30. Overall median follow-up was 39.8 months; 5 Fx 50.6 months, 4 Fx 25.8 months. Both groups received similar doses in equivalent 2 Gy fractions (EQD2) to the high-risk clinical target volume (HRCTV) (p = 0.26), and the 4 Fx group received significantly less dose to critical organs at risk (OARs) including the rectum (p = 0.02), sigmoid (p < 0.01), and bladder (p = 0.02). Comparing the 5 Fx group to the 4 Fx group, there was no significant difference in 5-year LRF (11.2% vs. 0.0%, p = 0.24) or in 5-year overall grade 3+ late toxicity (7.7% vs. 5.9%, p = 0.81). CONCLUSION Treatment of inoperable endometrial cancer with 4 Fx of brachytherapy boost compared to 5 Fx after EBRT does not compromise cancer control or toxicity and was associated with less dose to OARs; this de-escalation suggests potential to widen the therapeutic ratio for HDR brachytherapy boost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsBrachytherapyDose Fractionation, RadiationRadiotherapy, Image-GuidedHumansFemaleRetrospective StudiesAgedMiddle AgedAged, 80 and overTreatment OutcomeMagnetic Resonance Imaging

Stichwörter der Autor:innen

Brachytherapy boostBrachytherapy fractionationEndometrial cancerGynecologic brachytherapyMedically inoperable

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: groszkiewicza2@upmc.edu.
  • Department of Gynecologic Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.

Zitieren

APA

Groszkiewicz, A., Lesnock, J. L., Sukumvanich, P., Boisen, M., Courtney-Brooks, M., Berger, J., Taylor, S., Olawaiye, A., Garrett, A., Rush, S., Hajduk, M., Houser, C., Doraisamy, E., Kim, H., & Vargo, J. A. (2026). What is the optimal fractionation for image-based high-dose-rate brachytherapy boost in medically inoperable endometrial cancer: 4 versus 5 fractions?. Brachytherapy, 25(4), 616-623. https://doi.org/10.1016/j.brachy.2026.02.001

Vancouver

Groszkiewicz A, Lesnock JL, Sukumvanich P, Boisen M, Courtney-Brooks M, Berger J, et al. What is the optimal fractionation for image-based high-dose-rate brachytherapy boost in medically inoperable endometrial cancer: 4 versus 5 fractions?. Brachytherapy. 2026;25(4):616-623. doi:10.1016/j.brachy.2026.02.001

BibTeX
@article{Groszkiewicz2026,
  author = {Groszkiewicz, Abigail and Lesnock, Jamie L and Sukumvanich, Paniti and Boisen, Michelle and Courtney-Brooks, Madeleine and Berger, Jessica and Taylor, Sarah and Olawaiye, Alexander and Garrett, Alison and Rush, Shannon and Hajduk, Michael and Houser, Christopher and Doraisamy, Elangovan and Kim, Hayeon and Vargo, John Austin},
  title = {What is the optimal fractionation for image-based high-dose-rate brachytherapy boost in medically inoperable endometrial cancer: 4 versus 5 fractions?},
  journal = {Brachytherapy},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {616--623},
  doi = {10.1016/j.brachy.2026.02.001}
}
Kostenlos starten →